Skip to main content
BioNTech SE (BNTX)
NASDAQ: BNTX · Real-Time Price · USD
102.06
0.00 (0.00%)
At close: Apr 28, 2026, 4:00 PM EDT
100.71
-1.35 (-1.32%)
After-hours: Apr 28, 2026, 7:14 PM EDT

BioNTech SE Revenue

In the year 2025, BioNTech SE had annual revenue of 2.87B EUR with 4.32% growth. BioNTech SE had revenue of 907.40M in the quarter ending December 31, 2025, a decrease of -23.75%.

Revenue (ttm)
2.87B EUR
Revenue Growth
+4.32%
P/S Ratio
7.66
Revenue / Employee
367,606 EUR
Employees
7,807
Market Cap
25.81B USD

Revenue Chart

* This company reports financials in EUR.

History

Fiscal Year End Revenue Change Growth
Dec 31, 20252.87B118.80M4.32%
Dec 31, 20242.75B-1.07B-27.96%
Dec 31, 20233.82B-13.49B-77.94%
Dec 31, 202217.31B-1.67B-8.78%
Dec 31, 202118.98B18.49B3,834.63%
Dec 31, 2020 Pro Pro Pro
Dec 31, 2019 Pro Pro Pro
Dec 31, 2018 Pro Pro Pro
Dec 31, 2017 Pro Pro Pro
Dec 31, 2016 Pro Pro Pro

Revenue Definition

Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.

Full Definition

Related Stocks

Company Name Revenue
BeOne Medicines AG 5.34B
Incyte 5.14B
argenx SE 4.24B
Genmab 3.72B
Alnylam Pharmaceuticals 3.71B
Royalty Pharma 2.38B
Moderna 1.94B
Insmed 606.42M
Revenue Rankings

BNTX News

More News